-transparent.png){kind=logo}
Hyperthermia, with no signs of any underlying infection, may occur in the course of neuroleptic malignant syndrome, fatal catatonia, heat stroke, or malignant hyperthermia. We describe hyperthermia as a complication after discontinuance of antiparkinsonian treatment with levodopa/carbidopa and bromocriptine. Impaired nigrostriatal, hypothalamic, and mesolimbic dopaminergic functions could be involved in pathogenesis.
Related Publications
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
January 1996,
The Journal of international medical research,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
January 1977,
Advances in biochemical psychopharmacology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
August 1985,
Neurology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
September 1978,
Annals of neurology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
March 1978,
Lancet (London, England),
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
July 1993,
Movement disorders : official journal of the Movement Disorder Society,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
January 1978,
Pharmacology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
November 1986,
Clinical endocrinology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
June 1998,
Neurology,
L Figà-Talamanca, and
C Gualandi, and
L Di Meo, and
G Di Battista, and
G Neri, and
F Lo Russo
June 1980,
Journal of the neurological sciences,
